臭氧联合替比夫定治疗乙肝疗效观察

目的:研究臭氧联合替比夫定对乙肝的治疗效果。方法:将同期就诊的98例患者依志愿接受治疗为原则,分为治疗组与对照组。治疗组32例患者,予臭氧自血疗法联合替比夫定,臭氧自血疗法疗程3个月,替比夫定疗程18个月;对照A组28例患者,单独使用口服替比夫定,疗程18个月;对照B组38例患者,单独使用臭氧自血疗法,疗程3个月。比较3组治疗后各项指标的变化。结果:治疗组联合应答率46.9%,对照A组36.2%,对照B组39.5%。结论:臭氧自血疗法联合替比夫定与单用替比夫定治疗乙肝近期疗效比较,差异具有统计学意义(P<0.05)。

Objective：To study clinical effec- tive of the ozone and telbivudine treatment for HBV.Methods：Treatment of the same pe- riod 98 cases of patients receiving treatment in accordance with the principle of voluntary, for the treatment of 32cases of group therapy to ozone joint telbivudine tablets,ozone autohemotherapy treatment for 3 months,telbivu- dine tablets,treatment for 18 months;28cases as control group A,the use of oral telbivu- dine tablets alone,treatment for 18 months; 38cases for the control group B,given the ozone autohemotherapy for 3 months;over the same period three groups were detected the various targets.Results：The treatment group for a joint response rate was 46.9%; and- control group A was 36.2% ;control group B was 39.5% .Conclusion：Compared the ozone joint telbivudine tablets in the treatment of hepatitis B with telbivudine alone capsules have a significant difference in short-term efficacy（P 〈 0.05）.